Conclusion: XM's Cyprus FAQ says Trading Point of Financial Instruments Ltd acts as a market maker. The hook is clarity: market-maker execution is a business model, not by itself evidence of good or bad fills.
The same FAQ cites CySEC licence 120/10. A rigorous review should test execution data and conflict controls instead of relying on labels such as ECN or STP.
| Question | Evidence |
|---|---|
| Who is counterparty? | Client agreement |
| How are prices formed? | Execution policy |
| How is slippage handled? | Order data |
| Can orders be rejected? | Terms and logs |
Export fill records across normal and volatile periods, compare requested versus executed price, and include positive as well as negative slippage. A small anecdotal sample cannot prove the model's quality.
The 2026 XM review includes a trading-experience section. Treat its tests as one sample, not a universal result.
Entity and model checked September 3, 2026.